Catalent to open Japanese development lab

Catalent to open Japanese development lab

Related tags Pharmacology

Catalent Pharma Solutions will open a development lab for oral formulation in Japan, citing the popularity of fast dissolve formulations in the country as a key driver.

The 107,000sqft laboratory - which is being built in the southern Japanese city of Kakegawa – will focus on proof-of-concept studies for developers interested in using Catalent’s Zydis orally dispersible tablet technology.

David Heyens, President of Catalent Asia Pacific, said: “Fast dissolve formulations are of unique importance in Japan and were pleased to announce our new Zydis laboratory which we plan to complete by August 2014, facilitating wider partnership with the Japanese pharmaceutical industry through local access to proof of concept and feasibility studies.

The new laboratory facility - which is scheduled to be fully operational in September – will also expand the CMO’s manufacturing capacity for its OptiGel micro softgel technology which is already based at the site.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us

Products

View more

Webinars